Company intelligence / Profile preview

Deerland Probiotics & Enzymes

Kennesaw, Georgia, United Statesdeerland.com ↗

Ownership: Private
Development stage: Other

Overview

Deerland developed clinically studied branded ingredients such as DE111®, PreforPro®, and others. Clinical studies have shown benefits for gut microbiota composition, digestive regularity, immune support, sports performance enhancement, body composition improvement, and more. Their products are used in both human dietary supplements and pet nutrition applications.

Therapeutic areas: GastroenterologyMetabolic DisordersImmunologyWomen's Health
Modalities: ProbioticPrebioticEnzyme replacement therapy (for supplements)Bacteriophage-based supplement ingredientProtein (enzymes)Small molecule (antioxidants in Solarplast)
Industry: Non-Drug Biotech

Partnerships

Previously with Thione International for ThioZyme line; now integrated into ADM's global partnerships network.

Beyond the preview

Go deeper on Deerland Probiotics & Enzymes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deerland Probiotics & Enzymes.